Beyond pCR Prediction: Subtype-Specific Artificial Intelligence for Treatment Tailoring in Breast Cancer Neoadjuvant Therapy
Simple Summary Breast cancer comprises biologically distinct subtypes rather than a single disease, and each is treated with a different pre-surgery strategy. Clinicians want to know early whether a patient is likely to respond, because that could guide safer treatment adjustment. Artificial intelligence has therefore...